©The Author(s) 2023.
World J Gastrointest Endosc. May 16, 2023; 15(5): 407-419
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Table 2 Has the patient taken any of the following medications in the past year
| Drug | Yes | No | Maybe |
| Claritin (loratadine) | |||
| Zyrtec (cetirizine) | |||
| Allegra (fexofenadine) | |||
| Sudafed (pseudoephedrine) | |||
| Singulair (montelukast) | |||
| Rynatan (chlorpheniramine) | |||
| Pro-Air, Ventolin (albuterol) | |||
| Flovent (fluticasone) | |||
| Pulmicort (budesonide) | |||
| Advair (fluticasone/salmeterol) | |||
| Orapred (prednisone) | |||
| Xolair (omalizumab) | |||
| Flonase (fluticasone) | |||
| Nasonex (mometasone) | |||
| Nasacort (triamcinolone) | |||
| Rhinocort (budesonide) | |||
| Veramyst (fluticasone) | |||
| Omnaris (ciclesonide) | |||
| Astelin (azelastine) | |||
| Astepro (azelastine) | |||
| Patanase (olopatadine) | |||
| NasalCrom (cromolyn) |
- Citation: Kaur P, Chevalier R, Friesen C, Ryan J, Sherman A, Page S. Diagnostic role of fractional exhaled nitric oxide in pediatric eosinophilic esophagitis, relationship with gastric and duodenal eosinophils. World J Gastrointest Endosc 2023; 15(5): 407-419
- URL: https://www.wjgnet.com/1948-5190/full/v15/i5/407.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i5.407